drugset / Trial / NCT03057509

A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

NCT03057509

Phase 1 Withdrawn Massachusetts General Hospital
NaSingle-groupOpen-labelTreatment

Summary

This research study is designed to evaluate a type of scan called Ga-68-DOTA-TOC positron emission tomography (PET) scanning as a way of assessing carcinoid tumors.

Timeline

Start
2018-11
Primary completion
2019-10-31
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject 68Ga-DOTATOC Peptide Intravenous
Background Octreotide Peptide

Indications